Action Point Financial Planning’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
Other funds holding PTGX
Action Point Financial Planning's PTGX Position: Q3 2026 in Review
Action Point Financial Planning sold out of Protagonist Therapeutics (PTGX) in Q3 2026, closing a stake of 10 shares — an estimated $1.1K sold.
Action Point Financial Planning first reported a position in PTGX in Q2 2026 and held it in 1 quarter. The position peaked at $1.1K in Q2 2026. 380 funds tracked by Wall St. Rank hold PTGX as of Q3 2026.
- Action Point Financial Planning reported no remaining Protagonist Therapeutics position as of Q3 2026 after selling out during the quarter.
- Action Point Financial Planning sold 10 Protagonist Therapeutics shares in Q3 2026, an estimated $1.1K.
- Action Point Financial Planning first reported a position in Protagonist Therapeutics in Q2 2026 and held it in 1 quarter.
- Action Point Financial Planning's Protagonist Therapeutics position peaked at $1.1K in Q2 2026.
- 380 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q3 2026.
Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.